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Neural circuits are constantly monitored and supported by the surrounding microglial
cells, using finely tuned mechanisms which include both direct contact and release of
soluble factors. These bidirectional interactions are not only triggered by pathological
conditions as a S.O.S. response to noxious stimuli, but they rather represent an established
repertoire of dynamic communication for ensuring continuous immune surveillance and
homeostasis in the healthy brain. In addition, recent studies are revealing key tasks for
microglial interactions with neurons during normal physiological conditions, especially in
regulating the maturation of neural circuits and shaping their connectivity in an activity- and
experience-dependent manner. Chemokines, a family of soluble and membrane-bound
cytokines, play an essential role in mediating neuron-microglia crosstalk in the developing
and mature brain. As part of this special issue on Cytokines as players of neuronal plasticity
and sensitivity to environment in healthy and pathological brain, our review focuses on the
fractalkine signaling pathway, involving the ligand CX3CL1 which is mainly expressed by
neurons, and its receptor CX3CR1 that is exclusively found on microglia within the healthy
brain. An extensive literature largely based on transgenic mouse models has revealed
that fractalkine signaling plays a critical role in regulating a broad spectrum of microglial
properties during normal physiological conditions, especially their migration and dynamic
surveillance of the brain parenchyma, in addition to influencing the survival of developing
neurons, the maturation, activity and plasticity of developing and mature synapses, the
brain functional connectivity, adult hippocampal neurogenesis, as well as learning and
memory, and the behavioral outcome.
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INTRODUCTION
Among the many strategies used by cells to communicate one with
another, the repertoire of chemokines constitutes one of the most
tightly regulated systems. Often, a particular cell type is uniquely
expressing the ligand for a receptor that is selectively found on
another cell type, thereby conferring a high degree of specificity
to the ensuing signaling (Rossi and Zlotnik, 2000; Zlotnik and
Yoshie, 2000; Allen et al., 2007). This is the case of fractalkine,
a chemokine which signals directly from the producing neurons
to their effector microglia, the only cells expressing its cognate
receptor CX3CR1 in the healthy brain (Nishiyori et al., 1998;
Schwaeble et al., 1998; Maciejewski-Lenoir et al., 1999; Hughes
et al., 2002).
Fractalkine, also known as CX3CL1, is the only member of
the ∂ (CX3C) chemokine family, characterized by the presence
of 3 amino acidic residues (X3) localized between 2 cysteine
residues, thus forming a disulphide bond, a CX3C motif, and
also a transmembrane domain (Pan et al., 1997). The full-length
fractalkine protein consists of 397 amino acids encoded by the
Cx3cl1 gene mapped on the chromosome 16 in human (Bazan
et al., 1997; Pan et al., 1997) and of 395 amino acids encoded
by the neurotactin gene mapped on the chromosome 11 in
mouse (Rossi et al., 1998). Fractalkine is constitutively expressed
at high levels by neurons, mostly in forebrain structures such
as the hippocampus, amygdala, cerebral cortex, globus pallidus,
striatum and thalamus, but also in the olfactory bulb, with almost
no expression in the cerebellum, at the mRNA and protein levels
in adult mouse in situ (Tarozzo et al., 2003). In the brainstem, a
few scattered cells immunoreactive for fractalkine were initially
depicted by Tarozzo and colleagues, while significant expres-
sion of the protein was subsequently observed in situ (Heinisch
and Kirby, 2009; Ruchaya et al., 2012). Besides this neuronal
expression, fractalkine mRNA and protein was also shown to be
constitutively expressed by astrocytes, albeit at lower levels, in
adult mouse, rat and human brain in situ (Hulshof et al., 2003;
Sunnemark et al., 2005).
Fractalkine is a unique chemokine in that it exists in two
different forms: a membrane-bound protein tethered to neuronal
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membranes by a mucine-like stalk (approximately 95 kDa),
and a soluble factor released upon cleavage of its N-terminal
chemokine domain (approximately 70 kDa) (Garton et al., 2001).
Membrane-bound fractalkine has been proposed to act as an
adhesion molecule, whereas the diffusible form works as an
extracellular chemoattractant promoting cellular migration. This
function is shared with other members of the chemokines family,
commonly acting as “chemotactic cytokines” during innate and
adaptive immunity. The name “chemokines” is precisely derived
from this ability to mediate attraction of their responsive cells
(Bazan et al., 1997; Comerford and McColl, 2011; Pan et al., 2011;
Zlotnik and Yoshie, 2012).
Chemokine receptors belong to the family of G-protein cou-
pled receptors (GPCR), showing the presence of 7 transmem-
brane helices connected by several intra- and extracellular loops,
as well as N-terminal extracellular and C-terminal intracellu-
lar domains. The N-terminal extracellular domain is considered
important for chemokine binding and receptor activation, while
the C-terminal end is coupled to G-proteins, and is important
for receptor signaling upon chemokine binding. Based on their
primary amino acid sequence and the respective ligands that
they bind, chemokine receptors are also classified into four sub-
families, i.e., CXCR, CCR, CR and CX3CR (Proudfoot et al.,
2010). The fractalkine receptor CX3CR1 is a Gi-protein cou-
pled receptor encoded by the Cx3cr1 gene, previously named
V28, located on the chromosome 3 in human (Combadiere
et al., 1995) and the chromosome 9 in mouse (Combadiere
et al., 1998). The subunit protein Gi inhibits the production
of cAMP, triggering a variety of intracellular second messengers
including phosphoinositide 3-kinase (PI3K), protein kinase B
(AKT) and nuclear factor kappa-light-chain-enhancer of acti-
vated B cells (NFκB), which are well-known for mediating a
wide range of cellular functions, including apoptosis, prolif-
eration, transcription and migration (Al-Aoukaty et al., 1998;
Chandrasekar et al., 2003). CX3CR1 is ubiquitously expressed
by monocytes, dendritic cells, and natural killer cells throughout
the body (Imai et al., 1997; Combadiere et al., 1998; Harrison
et al., 1998; Jung et al., 2000). Since these cells rarely infiltrate
the brain parenchyma during normal physiological conditions,
resident microglia are considered the only source of CX3CR1
expression and thus the only recipient of fractalkine signal-
ing in the healthy brain (Jung et al., 2000; Mizutani et al.,
2012).
In recent years, microglia were demonstrated to originate from
yolk-sac derived progenitors infiltrating the brain during early
embryonic development, with no subsequent contribution to
their renewal from bone-marrow derived myeloid cells (Ginhoux
et al., 2010; Mizutani et al., 2012; Kierdorf et al., 2013). Microglia
were also shown to be extremely dynamic in their once presumed
“resting” state, continuously surveying the brain parenchyma
and contacting pre- and post-synaptic elements with their highly
motile processes (Davalos et al., 2005; Nimmerjahn et al., 2005;
Wake et al., 2009; Tremblay et al., 2010). Their physiological roles
discovered so far comprise the elimination of supernumerary
neurons and the maturation of synapses in the developing brain
(Hoshiko et al., 2012; Cunningham et al., 2013; Lenz et al.,
2013; Ueno et al., 2013), the regulation of neuronal and synaptic
activity (Li et al., 2012; Pascual et al., 2012), the elimination of
apoptotic newborn neurons generated in excess during adult hip-
pocampal neurogenesis (Sierra et al., 2010), and the activity- and
experience-dependent remodeling of neuronal circuits. Neuronal
circuit plasticity is required for learning and memory processes in
the developing and mature brain, where microglia contribute to
both the formation and elimination of synapses (Tremblay et al.,
2010, 2012; Paolicelli et al., 2011; Schafer et al., 2012; Parkhurst
et al., 2013).
The CX3CR1-GFP knock-in mouse line where the fractalkine
receptor gene has been replaced by a green fluorescent
protein (GFP) reporter (Jung et al., 2000), represents one
of the most important tools for studying microglial involve-
ment in the healthy brain. All microglial cells abundantly
express GFP, resulting in an exceptional fluorescent labeling of
their complex arborization, from cell body to distal processes
(Tremblay et al., 2010). Since the CX3CR1-GFP homozygous mice
(CX3CR1KO/KO) are completely devoid of microglial CX3CR1,
and therefore of fractalkine signaling, comparing the heterozy-
gous (CX3CR1KO/+) used for imaging with the homozygous
mice also provides a strategy for dissecting the molecular deter-
minants of neuron-microglia communication in a non-invasive
manner (Tremblay, 2011; Wolf et al., 2013). The CX3CR1-GFP
heterozygous mice may be partially deficient in fractalkine signal-
ing. Nevertheless, microglial morphology, dynamic surveillance
(Nimmerjahn et al., 2005; Wake et al., 2009), dendritic spine
turnover (Parkhurst et al., 2013), and microglial interactions with
synaptic elements (Wake et al., 2009; Tremblay et al., 2010) were
comparable in vivo between these CX3CR1-GFP heterozygous
mice and the Iba1-GFP mice from Hirasawa and colleagues where
CX3CR1 is not deleted (Hirasawa et al., 2005).
In the past few years, an extensive literature largely based
on the CX3CR1-GFP line revealed that fractalkine signaling
influences a broad spectrum of microglial physiological prop-
erties. Within this perspective, our focused review is dedicated
to the emerging roles of fractalkine signaling in the regulation
of microglial motility, as much as its consequences on neuronal
survival, synaptic pruning, maturation, function and plasticity,
hippocampal neurogenesis, the brain functional connectivity,
learning and memory, and on the behavioral outcome (see
Figure 1 for a schematic overview).
MODULATORY EFFECTS OF FRACTALKINE ON MICROGLIAL
PROPERTIES
Considering the crucial roles conferred by chemokines in
the immune system, the CX3CL1-CX3CR1 axis was similarly
expected to induce effector responses that are tightly adjusted
to the homeostatic needs of the neuronal circuitry in the brain.
Establishing microglial interactions with their dedicated neu-
ronal subsets might be one example. The first evidence for
such an important function comes from in vitro observations
by Maciejewski-Lenoir and colleagues that fractalkine exerts a
strong, dose-dependent migratory effect on cultured microglia
derived from newborn rats (Maciejewski-Lenoir et al., 1999).
Fractalkine application rapidly triggered changes in microglial
activity, on a time scale of minutes, as revealed by the elevation
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FIGURE 1 | The roles of CX3CL1-CX3CR1 interactions in the healthy
brain. During postnatal development, fractalkine signaling is promoting
microglial recruitment to neuronal circuits by increasing their process
dynamics and cellular migration, as well as modulating neuronal survival
via the release of trophic factors (A). During postnatal development and
adulthood, soluble and/or membrane-bound fractalkine further contribute
to the maturation, activity and plasticity of excitatory synapses by
promoting the maturation of NMDA receptors (transition from GluN2B to
GluN2A subunits), the multiplicity and efficiency of synaptic
transmission, the depression of AMPA receptors and potentiation of
NMDA receptors, and the modulation of LTP and LTD at the Schaffer
collateral synapse in the hippocampus CA1 (B), with lasting
consequences on the brain functional connectivity, learning and memory,
and the behavioral outcome. Additionally, fractalkine signaling might be
influencing the developmental pruning of synapses and adult
hippocampal neurogenesis by regulating microglial phagocytosis of
synaptic elements and newborn apoptotic cells during normal
physiological conditions (C).
of their intracellular calcium mobilization, which triggered a
cascade of signaling leading to their cytoskeletal rearrangement
and resulting in their migration. This response of microglia was
diminished with antibodies against CX3CR1 or pharmacological
inhibitors of the Gi subunit protein, supporting the functional
involvement of CX3CL1-CX3CR1 interactions (Maciejewski-
Lenoir et al., 1999).
Following these pioneering observations, Liang and colleagues
further investigated the effects of CX3CR1 signaling on microglial
dynamics ex vivo, by using time-lapse confocal imaging of reti-
nal explants from adult mice. In these experiments, microglial
processes were found to be significantly slower in the CX3CR1-
GFP homozygous mice (CX3CR1KO/KO), either during basal con-
dition or in response to focal laser-induced injury, compared with
heterozygous controls (CX3CR1KO/+). Not only was microglial
motility reduced in the CX3CR1 deficient microglia, but also
their migration towards the site of injury, which was determined
over minutes (Liang et al., 2009). Similarly, Zhang and colleagues
have provided evidence that fractalkine signaling is implicated in
the regulation of microglial migration in vitro, using microglia
freshly isolated from the retina of newborn rats, co-cultured
with a photoreceptor cell line. In this study, microglial migration
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quantified in a transwell chemotaxis assay was also found to
be reduced following treatment with neutralizing anti-CX3CR1
antibodies. Conversely, the addition of recombinant full-length
or soluble fractalkine resulted in an increased proportion of
microglial cells moving towards the photoreceptors (Zhang et al.,
2012).
In the developing hippocampus, Paolicelli and colleagues
also reported a slower increase of microglial density in the
CX3CR1KO/KO mice versus CX3CR1KO/+ littermates, between
postnatal days (P)8 and 28 in the CA1 region (Paolicelli et al.,
2011). A similar situation was recently described by Audinat
and colleagues in the somatosensory cortex, where microglial
infiltration normally occurs over the first postnatal days. In
this study, microglial numbers were found to be significantly
diminished among the centers of the barrel cortex which rep-
resent the whiskers, when comparing the CX3CR1KO/KO mice
with wild-type littermates at P5, but this effect was transient as
similar levels of microglial density were reached by P9 (Hoshiko
et al., 2012). More recently, microglial colonization of the motor
cortex duding early postnatal development was also shown to
be impaired in the absence of fractalkine signaling, resulting in
microglial accumulation within the subcortical white matter of
the CX3CR1KO/KO mice at P5 (Ueno et al., 2013). Considering
that CX3CL1 expression is normally upregulated in the brain over
the course of embryonic and postnatal maturation (Mody et al.,
2001), these observations support a chemoattractant function
of fractalkine signaling during normal development, particularly
aimed at recruiting microglial cells to the relevant neuronal
circuits, requiring specialized functional intervention during a
period of intense activity-dependent remodeling.
CONSEQUENCES OF FRACTALKINE ON NEURONAL CIRCUIT
FUNCTION AND PLASTICITY
SURVIVAL OF NEURONS
During normal development, microglia also contribute to the
elimination of supernumerary neurons in various brain regions,
including the cerebral cortex, hippocampus and cerebellum. The
proposed mechanisms comprise the release of superoxide ions
triggering apoptosis, the phagocytosis of non-apoptotic neural
precursors and newborn neurons, and the release of trophic
factors promoting neuronal survival (Marin-Teva et al., 2004;
Wakselman et al., 2008; Cunningham et al., 2013; Ueno et al.,
2013). Fractalkine signaling was recently involved in the latter
mechanism. In particular, apoptotic neurons immunopositive
for the cleaved-caspase 3 or detected with a TUNEL labeling of
DNA fragmentation were more frequently encountered within the
motor cortex of CX3CR1KO/KO mice versus wild-type controls at
P5 (Ueno et al., 2013). In this study by Ueno and colleagues,
the insulin-like growth factor 1 (IGF-1) was further identified
as a microglial factor preventing neuronal apoptosis. Interfering
with IGF-1 signaling significantly increased the number of dying
neurons in wild-type mice, using either intraventricular injection
of a peptide blocking autophosphorylation of the IGF-1 receptor
(H-1356), or a small hairpin (sh)RNA silencing gene expression of
IGF-1. In the CX3CR1KO/KO mice, mRNA expression of the IGF-1
binding protein 5 (IGFBP5) was also increased, and the free levels
of IGF-1 were decreased, while injection of IGFBP5 promoted
neuronal apoptosis (Ueno et al., 2013). These observations pro-
pose that CX3CL1-CX3CR1 interactions could serve to regulate
the number of neurons during normal development, notably by
promoting microglial release of trophic factors, even though the
signaling cascade mediating microglial release of IGF-1 upstream
of fractalkine signaling remains to be elucidated.
In a complementary manner, microglia were recently shown to
promote neurogenesis and oligodendrogenesis in the developing
rat brain, by releasing pro-inflammatory cytokines. Microglial
release of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)α
and interferon (IFN)γ was found to regulate subventricular zone
(SVZ) neurogenesis between P1 and P10. Systemic injection of
the anti-inflammatory antibiotic minocycline, which is com-
monly used to reduce microglial activation, was accompanied
by reduced levels of pro-inflammatory cytokines, and numbers
of proliferating cells, neuronal and oligodendrocytic progenitors.
In the somatosensory cortex, between P6 and P8, minocycline
was recently shown to increase neuronal death and microglial
activation (Arnoux et al., 2014), but in this study by Shigemoto-
Mogami and colleagues, the effects of minocycline on reducing
microglial activation were confirmed by a strong reduction in
activation markers such as CD11b and CD68. Interestingly, IGF-1
levels were not affected, thus suggesting that this signaling path-
way is not regulating the effects of microglia on neurogenesis in
the SVZ during the first postnatal days (Shigemoto-Mogami et al.,
2014).
MICROGLIAL PRUNING OF SYNAPSES
In the healthy brain, microglial cells also participate to the remod-
eling of neuronal circuits, an activity- and experience-dependent
process required for learning and memory, and proper behav-
ioral outcome, that is particularly exacerbated during postnatal
development, but still persists throughout adulthood and normal
aging. So far, microglial contacts with pre-synaptic axon ter-
minals and post-synaptic dendritic spines, sometimes accompa-
nied by their phagocytic engulfment and elimination, have been
documented in the cerebral cortex, hippocampus and thalamus
using a combination of cutting-edge microscopy techniques: tran-
scranial two-photon in vivo imaging (cerebral cortex), electron
microscopy with immunostaining and 3D reconstructions (cere-
bral cortex, hippocampus, thalamus), and stimulated-emission
depletion confocal microscopy (hippocampus) (reviewed in
Tremblay, 2011; Kettenmann et al., 2013). Using these techniques,
phagocytic inclusions identified as synaptic elements, based on
their ultrastructural features (i.e., 40 nm synaptic vesicles and
post-synaptic densities) or immunoreactivity for the synaptic
markers vesicular glutamate transporter 2 (Vglut2), post-synaptic
density protein 95 (PSD95), and synaptosomal-associated protein
25 (SNAP25), were visualized inside of microglial cell bodies and
processes (Tremblay et al., 2010; Paolicelli et al., 2011; Schafer
et al., 2012).
The involvement of fractalkine signaling in mediating the
elimination of synapses during normal development was par-
ticularly addressed by comparing the CX3CR1KO/KO mice with
CX3CR1KO/+ littermates in the hippocampus CA1 during the first
postnatal weeks. In the study by Paolicelli and colleagues, the
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decrease in microglial number was also found to be accompanied
by a transient increase in dendritic spine density on the pyramidal
neurons apical dendrites of the same region, thus indicating a
possible role for fractalkine signaling in mediating microglial
pruning of dendritic spines (Paolicelli et al., 2011). However, it
remains to be elucidated whether fractalkine signaling exclusively
instructs the recruitment of microglial cells to the proximity of
maturing dendrites, or, in addition, also contributes to directly
regulating microglial pruning itself.
In parallel, the work of Schafer and colleagues has shown that
microglial pruning of synaptic elements is determined during
postnatal development by the microglial complement 3 receptor
(C3R), since microglial phagocytosis of axon terminals was sig-
nificantly reduced in situ in the visual thalamus of C3R knockout
mice at P5 and P20, resulting in a sustained impairment of
synaptic density until P32–P35 at least (Stevens et al., 2007;
Schafer et al., 2012). The subsequent work of Linnartz and
colleagues additionally revealed that the classical complement
cascade becomes recruited by the changes in neuronal glycoca-
lyx in vitro. In particular, desialylated (i.e., lacking the terminal
sugar residue sialic acid) neurites were found to be preferentially
phagocytosed by microglial cells in primary culture via a CR3-
dependent mechanism (Linnartz et al., 2012), but the molecu-
lar relationships between fractalkine signaling and the classical
complement pathway remain unknown at this early stage of
investigation in the field.
FUNCTIONAL MATURATION OF SYNAPSES
A role for fractalkine signaling in modulating the postnatal
development of neuronal circuits was also lately proposed by
the work of Hoshiko and colleagues. In this study, the delayed
infiltration of microglial cells in the barrel cortex was accom-
panied by defects of synaptic maturation. Electrophysiological
analyses in acute thalamocortical slices from CX3CR1KO/KO mice
versus wild-type littermates revealed that CX3CR1 deletion affects
the functional maturation of postsynaptic glutamate receptors
which normally occurs at thalamocortical synapses in the first 2
postnatal weeks. During the first postnatal week, NMDA receptors
contain predominantly GluN2B subunits, replaced by GluN2A
subunits by the end of the second postnatal week to increase the
efficiency of synaptic transmission. Considered as an index of
synaptic maturation, this switch is associated with faster kinet-
ics of the NMDARs-mediated excitatory postsynaptic currents
(EPSC). This transition from GluN2B to GluN2A subunits was
precisely delayed in the CX3CR1 knockout mice. In particular,
the decay time of the NMDAR-mediated responses was found
to be significantly reduced at P9-10 in the CX3CR1KO/KO mice
compared with wild-type littermates, using single-cell recordings.
However, the defect was transient, without any remaining differ-
ence in the decay time of NMDAR-mediated responses at P27–
P33 (Hoshiko et al., 2012).
In addition, Zhan and colleagues recently reported differences
in the regulation of EPSCs in the CX3CR1KO/KO mice, by using
single-cell recording at the Schaffer collateral synapse in acute
hippocampal slices (Zhan et al., 2014). Both the miniature EPSCs
(mEPSC) and spontaneous EPSCs (sEPSCs) were investigated.
Since mEPSCs are recorded in presence of tetrodotoxin (TTX),
a sodium channel blocker that prevents action potential-induced
currents, they constitute a measure of post-synaptic currents
induced by random release of synaptic vesicles. On the other
hand, sEPSCs reflect currents triggered by an action potential,
and confer a measure of synaptic efficiency. The amplitude of
sEPSC arising from the action potential-dependent release of
synaptic vesicles normally increases over the course of postnatal
development, as functional synapses become increasingly formed
and neuronal networks properly interconnected, a process named
synaptic multiplicity. On the contrary, the amplitude of mEPSCs
remains relatively constant across the same age interval. The ratio
between sEPSCs and mEPSCs increases as neural circuits develop,
and can be considered as an index of neural circuit maturation
(Hsia et al., 1998). In littermate wild-type mice, the amplitude of
sEPSCs was found to be significantly larger than mEPSCs both at
P15 and P40. In CX3CR1 knockout mice, however, no significant
difference was observed between action potential- (sEPSCs) and
non-action potential-dependent (mEPSCs) currents at P15 and
later at P40, suggesting reduced synaptic multiplicity and less
efficient post-synaptic transmission when microglial function is
compromised. With the previous observations, these recent find-
ings support a crucial role for fractalkine signaling in regulating
the maturation of excitatory synapses during normal develop-
ment.
SYNAPTIC TRANSMISSION
In line with these observations, several studies have recently
revealed modulatory effects of fractalkine signaling on the elec-
trophysiological properties of excitatory synapses in acute hip-
pocampal slices. Ragozzino and colleagues have first reported that
fractalkine negatively modulates the AMPA receptors-dependent
component of glutamatergic transmission at the Schaffer collater-
als synapse. In this study, the application of fractalkine induced a
sustained, dose-dependent reduction of the evoked EPSC ampli-
tude in the CA1 region of acute hippocampal slices from P14–P22
mice and rats. This depression of EPSC was not observed in slices
from CX3CR1KO/KO mice, and specifically depended on AMPA
receptors function, being elicited by AMPA during the silencing of
endogenous synaptic transmission with TTX and bicuculline (an
antagonist of GABAA receptors), and suppressed by the AMPA
and kainate receptors blocker 6,7-dinitroquinoxaline-2,3-dione
(DNQX). In contrast, the NMDA receptors blocker D-amino-5-
phosphonovaleric acid (D-APV) produced no effects (Ragozzino
et al., 2006). Bertollini and colleagues similarly observed that
fractalkine induces a sustained but reversible depression of field
excitatory postsynaptic potentials (fEPSP), reflecting the postsy-
naptic response to the stimulation of Schaffer collaterals recorded
in a population of neurons, in the CA1 region of acute slices
derived from 21–29-day old mice. These effects were absent
in slices from CX3CR1KO/KO mice, and further suppressed in
wild-type mice after application of a CX3CR1 blocking antibody
(Bertollini et al., 2006). Nevertheless, the mechanisms by which
neuron to microglia crosstalk might contribute to these effects
of fractalkine signaling on glutamatergic synapses function still
remain unknown.
In this context, recent studies have suggested a possible
involvement of microglial release of adenosine, not only in
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mediating the depression of AMPA receptors function, but also
the potentiation of NMDA receptors function. A role for the
purine nucleoside adenosine was first proposed by the work
of Piccinin and colleagues, showing that fractalkine causes a
reversible depression of EPSCs in acute hippocampal slices from
14–20 days old mice, an effect that is prevented by treatment
with adenosine deaminase, an enzyme that irreversibly converts
adenosine to the related nucleoside iosine, and abolished by
the specific AR3 antagonist MRS1523, contrarily to the AR1
(DPCPX) and AR2 (SCH58261) antagonists. These observations
were corroborated by additional findings that fractalkine induces
EPSC depression in acute slices from AR1 and AR2 knock-
out mice, but not in slices from AR3 knockout mice (Piccinin
et al., 2010). More recently, Scianni and colleagues further pro-
posed that fractalkine-induced release of adenosine increases the
amplitude of fEPSPs resulting from the stimulation of Schaf-
fer collaterals, by acting on its NMDA dependent component
specifically. In this study, the effects of fractalkine on the fEPSP
were found to be abolished by the selective antagonist of NMDA
receptors 5,7-dichlorokynurenic acid (DCKA), the specific AR2
blocker SCH58261, and in acute slices from AR2 knockout mice,
thus suggesting a role for AR2 in mediating these effects. Upon
fractalkine stimulation, a significant increase in the concentration
of D-serine, a co-agonist of NDMA receptors, was also measured
by mass spectrometry analysis in the extracellular medium of
microglia and astrocyte primary cultures. Microglial (or astro-
cytic) release of D-serine might therefore potentiate NMDA
receptors function downstream of fractalkine signaling (Scianni
et al., 2013).
SYNAPTIC PLASTICITY
How fractalkine-induced alterations of postsynaptic glutamater-
gic responses modulate the propensity for long-term synaptic
plasticity was also recently investigated. In particular, Maggi and
colleagues have used fEPSP recordings at the Schaffer collater-
als synapse to reveal that fractalkine significantly inhibits long-
term potentiation (LTP) when administered during the critical
period for induction, in acute slices from 6–8 weeks old wild-
type mice. This impairment of LTP was however absent in slices
from CX3CR1KO/KO mice, and additionally found to require the
activation of AR3 receptors as it was prevented by the selective
antagonist MRS1523 (Maggi et al., 2009), in agreement with
the previous findings. Nevertheless, subsequent studies using
CX3CR1KO/KO mice to explore the effects of fractalkine signaling
on long-term plasticity, in acute slices from the hippocampus CA1
region, reported a complete absence of LTP (Rogers et al., 2011),
or a more sustained LTP than in wild-type littermates, when LTP
was induced by a weak stimulation protocol (Maggi et al., 2011).
This apparent discrepancy warranting further investigation might
result from differences in the ages, diet and housing conditions of
the animals, or electrophysiological preparation and stimulation
protocols between studies. Lastly, Paolicelli and colleagues also
examined the influence of fractalkine signaling on the induction
of long-term depression (LTD) in the CX3CR1KO/KO mice com-
pared to wild-type littermates, reporting no difference between
genotypes during adulthood (P40), despite a significant enhance-
ment of LTD in the CX3CR1KO/KO at P13 (Paolicelli et al., 2011),
thus suggesting the possibility that only LTP could be modulated
by fractalkine signaling in the mature healthy brain.
ADULT HIPPOCAMPAL NEUROGENESIS
Neurogenesis continues throughout life in the hippocampus,
where it was demonstrated to be necessary for synaptic plasticity,
including the induction of LTP and LTD, as well as classical
eye blink and fear conditioning, memory retention in spatial
learning tasks, and encoding of overlapping input patterns (Sierra
et al., 2014). Contributing to these processes, microglia have
been shown to regulate the neurogenic cascade during normal
physiological conditions, by their phagocytic elimination of apop-
totic newborn cells, an efficient process that is undeterred by
increased age or inflammatory challenge (Sierra et al., 2010).
Conversely, microglial physiological properties such as their pro-
liferation, migration and phagocytosis were recently found to be
modulated by soluble factors, such as vascular endothelial growth
factor (VEGF) released by neuronal progenitor cells (NPCs) when
implanted in the striatum of adult mice in vivo, as supported by
the work of Mosher and colleagues proposing that microglia are
not only influencing neurogenesis, but may also be regulated by
newborn cells (Mosher et al., 2012).
With respect to the involvement of fractalkine signaling,
Bachstetter and colleagues first revealed that the density of pro-
liferating, newly generated cells is significantly reduced in the
subgranular zone (SGZ) of 4 month old CX3CR1KO/KO mice
compared with CX3CR1KO/+ littermates. Conversely, chronic
treatment with fractalkine was found to promote neurogene-
sis in aged (22 months old) but not young (3 months old)
or middle-aged rats (12 months old), while an antagonist of
CX3CR1 produced opposite effects in young, middle-aged and
old rats (Bachstetter et al., 2011). In a follow-up study, comparing
CX3CR1KO/KO and CX3CR1KO/+ mice with wild-type littermates
further revealed that adult hippocampal neurogenesis is regulated
by fractalkine signaling in a gene-dose dependent manner, with
intermediate levels of neurogenesis measured in the heterozygous
mice (Rogers et al., 2011). Supporting these results, Maggi and
colleagues also described a reduced adult hippocampal neuro-
genesis in the SGZ of 13 to 14 weeks old CX3CR1KO/KO mice,
versus wild-type littermates, and further revealed that neurogen-
esis is positively regulated by chronic environmental enrichment,
even in the absence of CX3CR1 (Maggi et al., 2011). Neverthe-
less, the cellular and molecular mechanisms which are medi-
ating these effects downstream of fractalkine signaling remain
unknown.
FUNCTIONAL CONNECTIVITY
Lastly, Zhan and colleagues have recently shown that
CX3CR1KO/KO mice display a lasting impairment of synaptic
connectivity into adolescence, in the hippocampus CA1 region.
In particular, quantifying at the ultrastructural level the density
of multi-synaptic boutons, i.e., axon terminals making synapses
with 2 dendritic spines, revealed a significant reduction in the
knockout mice compared to wild-type littermates at P40. These
data support the hypothesis that in the absence of fractalkine
signaling, compromised neuron-microglia interactions are
affecting the efficiency of synaptic transmission (Zhan et al.,
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2014) despite a normalized density of dendritic spines which
was observed by the same group in adult animals (Paolicelli
et al., 2011). In addition, local field potentials (LFPs) were
investigated by Zhan and colleagues by performing in vivo
recordings at P40. LFPs inform about the overall levels of
electrical activity measured in a certain volume, resulting
from the sum of synaptic activity. As a measure of long-range
connectivity, coherence spectra of the LFPs measured locally
were calculated, under the premise that high coherence values
reflect strongly connected structures. By implanting electrodes
within different brain regions simultaneously, a significant
decrease in the coherence between the hippocampus and the
prefrontal cortex was found in CX3CR1KO/KO adult mice,
compared to wild-type littermates, thus reflecting a decrease in
functional connectivity. Interestingly, the coherence between the
hippocampus and the prefrontal cortex was also investigated in
behaving mice, during bouts of social investigation, revealing
a significant increase in coherence following the onset of social
investigation in wild-type mice, but not in CX3CR1 knockouts.
In line with these results, the global functional connectivity
assessed by functional magnetic resonance imaging (fMRI)
showed a significant reduction in the connectivity across brain
regions, becoming particularly evident for distant regions,
in the CX3CR1KO/KO mice versus wild-type controls (Zhan
et al., 2014). These recent findings are complementing one
another in supporting a fundamental role for CX3CL1-CX3CR1
interactions in mediating the development and plasticity of
neuronal circuits, at the molecular, cellular and neuronal circuit
levels.
CONSEQUENCES ON LEARNING, MEMORY, AND BEHAVIOR
At the behavioral level, Rogers and colleagues also reported
deficits in different forms of learning and memory in 3 month
old CX3CR1KO/KO mice, in parallel with the alteration of LTP.
In particular, motor learning was found to be compromised
in the CX3CR1 knockouts, compared to wild-type littermates,
using standard rotarod training (Rogers et al., 2011). Locomo-
tor and exploratory activity was however similar between the
two genotypes, when assessed in the open field test, and no
difference was observed in anxiety behavior, measured by the
elevated plus maze. In addition, associative learning and mem-
ory was altered in a standard fear-conditioning paradigm: after
a similar freezing behavior in the training session, knockout
mice failed to display associative learning (i.e., reduced freez-
ing) when tested 24 h later in the same environment (Rogers
et al., 2011). On the contrary, mice exposed to conditioning
in a novel environment displayed a similar freezing behav-
ior across genotypes, probably underlying hippocampal-specific
deficits in cognition, considering that context-specific types of
associative memory predominantly depend on the hippocampus
(Sousa et al., 2006; Crawley, 2008). The CX3CR1 knockouts
also displayed deficits when performing the water maze test,
thus further supporting a role for fractalkine signaling in mod-
ulating hippocampal-dependent learning and memory. These
effects could be mediated by microglial release of the pro-
inflammatory cytokine IL-1β since intrahippocampal infusion of
its antagonist IL-1ra significantly reversed the deficits in cognitive
function measured in the CX3CR1 knockouts (Rogers et al.,
2011).
However, Maggi and colleagues revealed that the
CX3CR1KO/KO mice are not significantly different from aged-
matched wild-type controls in their ability to learn the water
maze task, when they are tested at 13 to 14 weeks of age,
even though they fail to perform better following prolonged
exposure to an enriched environment, compared with standard
housing conditions. Since environmental enrichment also failed
to increase LTP, as well as adult hippocampal neurogenesis
in parallel experiments, it has been proposed that CX3CR1
deficiency could increase hippocampal plasticity as well as
spatial memory, thereby blunting the potentiating effects of the
environmental enrichment (Maggi et al., 2011). Here again, the
discrepancy between studies is unclear, possibly resulting from
differences in the animals or behavioral paradigms and analyses.
Interestingly, social interaction was also found to be altered
in the CX3CR1KO/KO mice, both early in life and into adult-
hood. Impaired social behavior was observed in juvenile mice,
displaying no preference for their own mother over an inert
stimulus, as assessed by the homing test. However, no impair-
ment in performing the novel object recognition test was
observed in the same mice. Similarly, adult CX3CR1 knockout
mice tested in a standard three-chamber apparatus failed to
display significant interest towards a sex-matched social stim-
ulus, compared to wild-type controls (Zhan et al., 2014). No
deficit in responding to social olfactory cues was reported
in these mice, suggesting that the impairment observed in
social behavior was due to reduced social motivation, rather
than difficulties with the discrimination of social cues. Addi-
tionally, increased grooming behavior was reported in adult
CX3CR1 knockout mice, when tested in a novel cage for
10 min, suggesting a propensity for increased repetitive behavior,
particularly triggered under stressful conditions (Zhan et al.,
2014).
CONCLUSION
In recent years, a combination of imaging, electrophysiol-
ogy, and behavioral analyses performed in the CX3CR1KO/KO
mice, versus CX3CR1KO/+ or wild-type littermates, have revealed
that CX3CL1-CX3CR1 signaling crucially regulates the devel-
opment and plasticity of neuronal circuits, with functional
consequences on the brain connectivity, adult hippocampal
neurogenesis, learning and memory, and the behavioral per-
formance. Since microglia are the only cell type expressing
CX3CR1 in the healthy brain, they might be crucially involved
in every one of these processes shown to be influenced by
fractalkine signaling during normal physiological conditions: the
survival of newborn neurons, the maturation and elimination
of synapses, the regulation of synaptic transmission, long-
term synaptic plasticity, and adult hippocampal neurogenesis.
Nevertheless, the microglial effector functions which are pre-
cisely recruited, the molecular mechanisms acting downstream
of CX3CL1-CX3CR1 interactions, much as the respective con-
tributions of soluble versus membrane-bound fractalkine to
these essential processes of normal physiology remain to be
elucidated.
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